<List><item><source>MED</source><extId>30361291</extId><pmcid>PMC6265616</pmcid><annotations><annotation><prefix> polymorphism (SNP) </prefix><exact>rs9344</exact><postfix> and cancer risk is </postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/abstract/MED/30361291#europepmc-bedda8ed2147fa2fc57ee95e1316b395</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>CCND1 polymorphism (</prefix><exact>rs9344</exact><postfix>) was not significan</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/abstract/MED/30361291#europepmc-51b1f01b08d5d304c33d36bae1ee330f</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>ith reference to CCND1 polymorphism (</prefix><exact>rs9344</exact><postfix>). </postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/abstract/MED/30361291#europepmc-2418b6ac4818c7acab58e377f441e228</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix> CCND1 polymorphism </prefix><exact>rs9344</exact><postfix> may not have a role</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/abstract/MED/30361291#europepmc-8f3a6c28397400935be4ef1220230eef</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>SNP) in CCND1 gene (</prefix><exact>rs9344</exact><postfix>) G870A, may influen</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-b24d7d526bcc0a0700aff1319a0025bc</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>n G/A SNP [dbSNP ID </prefix><exact>rs9344</exact><postfix>] was first describe</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-ad1034bbeb4e528dca10dd8c77e3e9ff</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>This SNP </prefix><exact>rs9344</exact><postfix> is located at codon 242 in the</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-4803420d1b9a066c6e16eb962ebd4c60</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix> between CCND1 SNP (</prefix><exact>rs9344</exact><postfix>) and cancer suscept</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-1facd5517746fa656cf4247ae1b246d4</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>polymorphism G870A (</prefix><exact>rs9344</exact><postfix>) in overall cancer </postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-e803785589758b780118fba8d0d89760</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>en CCND1 SNP G870A (</prefix><exact>rs9344</exact><postfix>) and cancer suscept</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-615cad09dc7e6dc9ce8314869adeb8ad</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>G870A polymorphism (</prefix><exact>rs9344</exact><postfix>) was performed by R</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-65903ee016eea0cc3aa9398d3682f274</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>a-analysis of CCND1 G/A polymorphism (</prefix><exact>rs9344</exact><postfix>) </postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-25e127fd4dbd8660e09bd86a08dd17ce</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>CCND1 polymorphism (</prefix><exact>rs9344</exact><postfix>) and cancer risk in</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-9fec11aaf8c39a816e5924509ffad431</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>polymorphism G870A (</prefix><exact>rs9344</exact><postfix>) is not associated </postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-3f542cba417ba2601b2899fc0292b86f</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>CCND1 polymorphism (</prefix><exact>rs9344</exact><postfix>) (Figures 3–6 and</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-2e516c79f0accbf70e22e99ea1bf1f26</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>CCND1 polymorphism (</prefix><exact>rs9344</exact><postfix>) and overall cancer</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-149ca9a8d9bfc0c636afac8f05e30167</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>CCND1 polymorphism (</prefix><exact>rs9344</exact><postfix>) and overall cancer</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-149ca9a8d9bfc0c636afac8f05e30167</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>A SNP G870A (</prefix><exact>rs9344</exact><postfix>) located on exon-4–intro</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-076bdae9d79727989135ec58a7fc9c3b</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>G870A polymorphism (</prefix><exact>rs9344</exact><postfix>) and overall cancer</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-06f9e4278b41583c98f9a4e35197c134</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>�AA’ genotype for </prefix><exact>rs9344</exact><postfix> SNP located on CCND</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-6cc2ae847ad9b47b29822bfe2abb62d8</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>ween the CCND1 SNP (</prefix><exact>rs9344</exact><postfix>) and overall risk f</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-75819080d56d30019076a3f71f1a6d98</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>bing that CCND1 SNP </prefix><exact>rs9344</exact><postfix> is not having role </postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-0969995c9e4c50eda6c5fb01cfc8f466</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>CCND1 polymorphism (</prefix><exact>rs678653</exact><postfix>) located on the 3�</postfix><tags><tag><name>rs678653</name><uri>http://identifiers.org/dbsnp/rs678653</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-174349bd1aad5849a5857b80fd9978ca</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>ymorphism under investigation G870A (</prefix><exact>rs9344</exact><postfix>). </postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-06ccc0f593d0f1bce0bcc75c082dbefc</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation><annotation><prefix>wed that CCND1 SNP (</prefix><exact>rs9344</exact><postfix>) may not serve as a</postfix><tags><tag><name>rs9344</name><uri>http://identifiers.org/dbsnp/rs9344</uri></tag></tags><id>http://europepmc.org/articles/PMC6265616#europepmc-507fa86eda9abeda83e4a575720898b0</id><type>Accession Numbers</type><section>Conclusion (http://purl.obolibrary.org/obo/IAO_0000615)</section><provider>Europe PMC</provider><subType>RefSNP</subType></annotation></annotations></item></List>